Tuba Baydas

7PUBLICATIONS
71CO-AUTHORS
Molecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer geneticsAboriginal and Torres Strait Islander health servicesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 27, 2026
Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy.

|May 27, 2026
Risk Tier, Variant Certainty, and Real-World Care Patterns in Breast Cancer Patients with Germline Alterations in Breast Cancer Susceptibility Genes.

|Mar 27, 2026
Comparable Access, Different Outcomes: Breast Cancer Survival Among Syrian Refugees and Turkish Patients in Türkiye.

Ilker Nihat Ökten, Tuba Baydaş, Canan Karan

|Jan 28, 2026
Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study.

İlker Nihat Ökten, Tuba Baydaş, Mahmut Emre Yıldırım

|Apr 18, 2024
Analysis of the Prophylactic use of Hydroxychloroquine at the Beginning of the COVID-19 Pandemic Among Physicians.

Mehmet Gökhan Gönenli, İlker Kayı, Nilüfer Alpay-Kanıtez

Pageof 2

Frequent Collaborators

5 joint publications

İlker Nihat Ökten

3 joint publications

İbrahim Çil

2 joint publications

Ayberk Bayramgil

2 joint publications

Hacı Mehmet Türk